2017 Symposium

2016 Symposium

2015 Symposium

2015 Agenda and Bios

2015 Symposium Photos

2014 Symposium

2014 Agenda and Bios

2013 Featured Talks

2013 Symposium Photos

Previous Symposia

2014 Featured Talks » Preclinical and early clinical activity of STAT3RX/AZD9150, A NEXT GENERATION ANTISENSE OLIGONUCLEOTIDE TARGETING STAT3



Part One

Part Two

Preclinical and early clinical activity of STAT3RX/AZD9150, A NEXT GENERATION ANTISENSE OLIGONUCLEOTIDE TARGETING STAT3


Robert MacLeod, PhD
Isis Pharmaceuticals




Robert MacLeod, PhD
Vice President, Oncology & Exploratory Discovery
Isis Pharmaceuticals